Biotechnology
Kenvue CEO says consumers are spending on brand-name health products even as they pull back in other areas
Thibaut Mongon, CEO of Kenvue Inc. a Johnson & Johnson’s consumer-health business, speaks during an interview to celebrate its IPO at the New York Stock Exchange (NYSE), May 4, 2023. Brendan Mcdermid | Reuters Most consumers have pulled back on spending as inflation squeezes their wallets, but they have not stopped paying up for brand-name […]
Read More
Johnson & Johnson investors can soon swap their shares for Kenvue stock — here’s what you need to know
Thibaut Mongon, CEO and Paul Ruh CFO of Kenvue Inc. a Johnson & Johnson’s consumer-health business, pose together during the company’s IPO at the New York Stock Exchange (NYSE) in New York City, U.S., May 4, 2023. Brendan McDermid | Reuters Johnson & Johnson on Thursday said its shareholders will soon be able to swap […]
Read More
Kenvue earnings top estimates in J&J spinoff’s first quarterly report since IPO
Kenvue, a unit of Johnson & Johnson’s consumer health business. CFOTO | Future Publishing | Getty Images Kenvue reported second-quarter revenue and adjusted earnings that topped expectations Thursday in the consumer health company’s first quarterly report since it spun out from Johnson & Johnson two months ago. The company also issued an upbeat sales outlook […]
Read More
Johnson & Johnson beats on earnings, hikes full-year guidance as medtech sales surge
Johnson & Johnson on Thursday reported second-quarter revenue and adjusted earnings that topped Wall Street’s expectations, and lifted its full-year guidance as sales from the company’s medtech business jumped. The medtech division provides devices for surgeries, orthopedics and vision. The company is benefitting from a rebound in demand for non-urgent surgeries among older adults, who […]
Read More
Pfizer Group B strep vaccine for infants returns encouraging mid-stage trial results
Streptococcus agalactiae bacteria, responsible for vaginal and urinary tract infections and newborn infections including meningitis and septicemia. Optical microscopy view. Cavallini James | BSIP | Universal Images Group | Getty Images Pfizer on Wednesday said its experimental vaccine targeting the potentially deadly bacterial disease Group B Streptococcus returned strong mid-stage clinical trial results, a promising […]
Read More
Medicare proposes removing limit on PET scans used to help diagnose Alzheimer’s disease
Jay Reinstein, who suffers from Alzheimer’s, sits on a bed after receiving a PET scan at MedStar Georgetown University Hospital in Washington, DC on June 20, 2023. Michael Robinson Chávez | The Washington Post | Getty Images Medicare plans to expand its coverage of PET scans that are used to help diagnose Alzheimer’s disease, a […]
Read More
Johnson & Johnson sues Biden administration over Medicare drug price negotiations
Pavlo Gonchar | LightRocket | Getty Images Johnson & Johnson on Tuesday sued the Biden administration over Medicare’s new powers to slash drug prices, making it the third pharmaceutical company to challenge the controversial provision of the Inflation Reduction Act. The lawsuit filed in federal district court in New Jersey argues the Medicare negotiations violate […]
Read More
Novartis stock jumps after drugmaker raises full-year guidance, launches $15 billion buyback
Novartis said in August that it plans to spin off its generics unit Sandoz to sharpen its focus on its patented prescription medicines. Bloomberg | Bloomberg | Getty Images Novartis shares jumped on Tuesday after the Swiss drugmaker raised its full-year guidance on strong drug sales and announced a $15 billion share buyback. The company […]
Read More
Nearly 3 million people cut from Medicaid coverage even though many might still be eligible
Supporters hold up Save Medicaid signs during the Senate Democrats’ news conference at the Capitol with disability advocates to oppose the Republicans’ Graham-Cassidy health care bill. Bill Clark | CQ-Roll Call, Inc. | Getty Images Nearly 3 million people have been kicked off Medicaid since Covid-19 pandemic protections expired in April, with three-quarters of those […]
Read More
Fda approves AstraZeneca, Sanofi shot that shields infants and toddlers versus RSV
Blood sample for respiratory syncytial virus (RSV) test Jarun011 | Istock | Getty Visuals The Meals and Drug Administration on Monday accredited AstraZeneca and Sanofi‘s shot that guards infants and toddlers versus respiratory syncytial virus, which is the leading trigger of hospitalization between infants in the U.S. Nirsevimab is the initial shot authorised by the […]
Read More